Cision Newshttps://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Tue, 09 Jun 2026 11:24:23 GMTCision News14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pngEmbla Medical hf: Transactions in relation to Share Buyback Programhttps://news.cision.com/embla-medical-hf-/r/embla-medical-hf--transactions-in-relation-to-share-buyback-program,c4358991cision5379345Mon, 08 Jun 2026 15:00:00 GMTInify Laboratories signs agreement with University Hospitals Plymouth NHS Trust to support faster prostate cancer diagnosticshttps://news.cision.com/inify-laboratories-ab/r/inify-laboratories-signs-agreement-with-university-hospitals-plymouth-nhs-trust-to-support-faster-pr,c4359245cision5379282Mon, 08 Jun 2026 13:13:37 GMTNotice of Extraordinary General Meeting of Terveystalo Plchttps://news.cision.com/terveystalo-oyj/r/notice-of-extraordinary-general-meeting-of-terveystalo-plc,c4358786cision5378686Mon, 08 Jun 2026 05:10:00 GMTInside information: Terveystalo to acquire Silmäasema to accelerate growth and increase presence in the growing eye care markethttps://news.cision.com/terveystalo-oyj/r/inside-information--terveystalo-to-acquire-silmaasema-to-accelerate-growth-and-increase-presence-in-,c4358792cision5378682Mon, 08 Jun 2026 05:05:00 GMTInside information: Terveystalo updates its strategic focus, financial targets for the medium term and dividend policyhttps://news.cision.com/terveystalo-oyj/r/inside-information--terveystalo-updates-its-strategic-focus--financial-targets-for-the-medium-term-a,c4358781cision5378677Mon, 08 Jun 2026 05:00:00 GMTOriola Oyj: Acquisition of own shares during week 23, 2026https://news.cision.com/oriola-oyj/r/oriola-oyj--acquisition-of-own-shares-during-week-23--2026,c4358612cision5378508Fri, 05 Jun 2026 16:00:00 GMTCORRECTION: Oriola Corporation's Annual Report 2025 publishedhttps://news.cision.com/oriola-oyj/r/correction--oriola-corporation-s-annual-report-2025-published,c4358461cision5378321Fri, 05 Jun 2026 10:00:00 GMTEye Health New E-Book Initiative from AstaRealhttps://news.cision.com/astareal/r/eye-health-new-e-book-initiative-from-astareal,c4357775cision5377561Thu, 04 Jun 2026 07:37:46 GMTZinzino AB (publ.): 250 International chefs and sommeliers recognize Zinzino’s BalanceOil+ with 2026 Superior Taste Awardhttps://news.cision.com/zinzino/r/zinzino-ab--publ--250-international-chefs-and-sommeliers-recognize-zinzino-s-balanceoil--with-2026-s,c4357234cision5376521Wed, 03 Jun 2026 12:15:00 GMTZINZINO AB (PUBL.): PRELIMINARY SALES REPORT MAY 2026https://news.cision.com/zinzino/r/zinzino-ab--publ--preliminary-sales-report-may-2026,c4356932cision5376151Wed, 03 Jun 2026 07:00:00 GMTZINZINO AB (PUBL.): ANNOUNCEMENT FROM THE ANNUAL GENERAL MEETINGhttps://news.cision.com/zinzino/r/zinzino-ab--publ--announcement-from-the-annual-general-meeting,c4356431cision5375287Tue, 02 Jun 2026 09:30:00 GMTMedia advisoryhttps://news.cision.com/who-regional-office-for-europe/r/media-advisory,c4356429cision5375277Tue, 02 Jun 2026 09:14:31 GMTZepzelca® (lurbinectedin) in combination with atezolizumab approved by the European Commission as first-line maintenance therapy for extensive-stage small cell lung cancerhttps://news.cision.com/immedica-pharma-ab/r/zepzelca---lurbinectedin--in-combination-with-atezolizumab-approved-by-the-european-commission-as-fi,c4356147cision5374721Mon, 01 Jun 2026 15:07:35 GMTEmbla Medical hf: Transactions in relation to Share Buyback Programhttps://news.cision.com/embla-medical-hf-/r/embla-medical-hf--transactions-in-relation-to-share-buyback-program,c4355756cision5374709Mon, 01 Jun 2026 15:00:00 GMTLOARGYS® (pegzilarginase for injection) approved in Canada for the treatment of Arginase 1 Deficiency (ARG1-D)https://news.cision.com/immedica-pharma-ab/r/loargys---pegzilarginase-for-injection--approved-in-canada-for-the-treatment-of-arginase-1-deficienc,c4356380cision5374687Mon, 01 Jun 2026 14:43:00 GMTAmbea strengthens its offering within child and youth care through an acquisition in Finlandhttps://news.cision.com/ambea/r/ambea-strengthens-its-offering-within-child-and-youth-care-through-an-acquisition-in-finland,c4355366cision5374246Mon, 01 Jun 2026 07:53:27 GMTQlife enters fully funded feasibility agreement with global pharma company for Egoo Health biomarker applicationhttps://news.cision.com/qlife-holding-ab/r/qlife-enters-fully-funded-feasibility-agreement-with-global-pharma-company-for-egoo-health-biomarker,c4355570cision5374188Mon, 01 Jun 2026 07:00:00 GMTOriola Oyj: Acquisition of own shares during week 22, 2026https://news.cision.com/oriola-oyj/r/oriola-oyj--acquisition-of-own-shares-during-week-22--2026,c4355374cision5373674Fri, 29 May 2026 16:00:00 GMTEU and WHO scale up action to respond to the Ebola outbreak in DRC and Ugandahttps://news.cision.com/who-regional-office-for-europe/r/eu-and-who-scale-up-action-to-respond-to-the-ebola-outbreak-in-drc-and-uganda,c4355319cision5373562Fri, 29 May 2026 14:18:15 GMTNew number of shares and votes in Ambea AB (publ)https://news.cision.com/ambea/r/new-number-of-shares-and-votes-in-ambea-ab--publ-,c4354830cision5373542Fri, 29 May 2026 14:00:00 GMTMEDIA TOOLKIThttps://news.cision.com/who-regional-office-for-europe/r/media-toolkit,c4354001cision5371635Wed, 27 May 2026 12:01:53 GMTBulletin from the Annual General Meeting 2026 of Qlife Holding ABhttps://news.cision.com/qlife-holding-ab/r/bulletin-from-the-annual-general-meeting-2026-of-qlife-holding-ab,c4353621cision5371419Wed, 27 May 2026 10:01:45 GMTInify Laboratories announces CQC registration and full operational launch of its state-of-the-art UK histopathology laboratoryhttps://news.cision.com/inify-laboratories-ab/r/inify-laboratories-announces-cqc-registration-and-full-operational-launch-of-its-state-of-the-art-uk,c4353790cision5371234Wed, 27 May 2026 08:15:51 GMTAstaxin Stockholm now featured in Yasuragi’s spring treatmenthttps://news.cision.com/astareal/r/astaxin-stockholm-now-featured-in-yasuragi-s-spring-treatment,c4353720cision5371126Wed, 27 May 2026 07:11:42 GMT